与抗瘤剂相关的乙型肝炎病毒的重新激活:研究进展和分子机制
Huajie Xie1, Meijun Lv1, Qin Jia1
1Department of Laboratory Medicine, The General Hospital of Western Theater Command, Chengdu, Sichuan Province, PR China.
Virus research
|November 3, 2025
概括
乙型肝炎病毒 (HBV) 再激活是癌症免疫疗法 (ICI) 期间的风险. 本综述涵盖了HBV再激活,其与ICI相关的风险,以及患者安全的管理策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 乙型肝炎病毒 (HBV) 感染是全球重要的健康问题.
- 由于缺乏治疗HBV的治疗方法,许多人面临重新激活的风险.
- 肝细胞癌 (HCC) 和其他恶性瘤越来越多地用免疫检查点抑制剂 (ICI) 治疗.
研究的目的:
- 审查HBV重新激活的定义,患病率和病原体.
- 讨论与ICI治疗相关的HBV再激活的风险和机制.
- 概述ICI治疗期间HBV的管理策略和监测建议.
主要方法:
- 关于HBV再激活和ICI治疗的综合文献综述.
- 对HBV重新激活的流行率和风险因素的研究分析.
- 综合当前的管理指南和专家建议.
主要成果:
- 在ICI治疗恶性瘤期间,HBV的重新激活构成了重大的临床挑战.
- 了解病原体对于预测和预防重新激活至关重要.
- 在接受ICI的患者中,主动查和对HBV状态的监测至关重要.
结论:
- 乙型肝炎病毒的重新激活使癌症治疗复杂化,需要谨慎管理.
- 实施推的查和监测协议可以减轻风险.
- 需要进一步的研究,以优化在接受ICI治疗的患者中针对HBV再激活的预防策略和治疗方案.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
556
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
556
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
799
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
799


